JUSTINE SICARI: Open Payments
NPI 1396387114 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,499 in 35 payments from 10 companies in 2025. Trend: 2023 $848 · 2024 $1,667 · 2025 $2,499
Food & beverage: $1,421Consulting: $900Travel & lodging: $120Education: $57
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 11 | $1,263 |
| AstraZeneca Pharmaceuticals LP | 11 | $427 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $313 |
| Verona Pharma, Inc. | 2 | $172 |
| Pulmonx Corporation | 1 | $161 |
| SANOFI-AVENTIS U.S. LLC | 1 | $57 |
| Regeneron Healthcare Solutions, Inc. | 2 | $53 |
| Viatris Specialty LLC | 1 | $25 |
| Electromed, Inc. | 1 | $14 |
| Insmed, Inc. | 1 | $14 |
Products named: NUCALA, OFEV, Ohtuvayre, CHARTIS CATHETER, DUPIXENT, FASENRA, TEZSPIRE, YUPELRI.
Industry payments across PA — which companies pay providers there.
